Home-grown drug makers enjoy 80 per cent share of the domestic market and take the lion’s share when it comes to brand launches. The data shows that in the last 12 months, multinational drugmakers have also done equally well in the Indian market in terms of growth rate.
According to the data from market research firm AIOCD AWACS, the moving annual turnover growth for November 2019 (which represents the last 12 months) for Indian firms is 9.9 per cent, while for multinational drug firms, it is at 9.7 per cent. During this period, the overall pharma market grew by 9.8 per